24 results

Drug delivery business Avectas has licensed a therapy from Galway-based ONK Therapeutics that targets what are called B-cell malignancies – blood cell cancers such as non-Hodgkin’s lymphoma (above)

(...) cancer cells that have made themselves invisible to normal natural killer cells. It has also added(...)

Social distancing rules mean laboratories are also struggling to process tests that have already been taken. Photograph: Rafe Swan/Cultura/Getty

(...) cases that has yet, thankfully, to materialise. The Irish Cancer Society and private medical(...)

People are staying away from doctors and hospitals during the Covid crisis even when they have potentially serious medical conditions, according to new data.

(...) business Diaceutics said it has seen a sharp drop in the number of patients presenting for cancer testing(...)

Dr Elaine Sullivan who co-founded Carrick Therapeutics. File photograph: Dave Meehan/The Irish Times

(...) deliver breakthrough therapies targeting the spread of cancer cells and also a form of ovarian cancer(...)

  Cancer patient Maria Waters requires a drug that is not licensed in the State for the treatment of   head and neck cancer. Photograph:    Nick Bradshaw

The husband of a woman with stage four cancer has called on pharma company MSD to provide her with(...)

 Maria Waters: she  has been advised by three consultants that Pembro is the best course of treatment for her cancer. Photograph: Nick Bradshaw

The husband of a cancer patient has written to Irish medicines regulators urging them to act(...)

Ger Brennan, who trained as a nurse, was keen to merge his medical interest with sales. After ‘a hundred PFOs’ applying to be a medical rep he landed a contract job with Bayer

(...) team put in then, and over the subsequent two years, means Brexit is not a worry now. Cancer therapies(...)

“While there’s been significant progress in treating solid tumour cancers overall with targeted therapies, patients with the KRAS G12C mutation have not benefited from these advances.”  Photograph: Getty Images

(...) “undruggable” gene mutation, potentially paving the way for a new cancer treatment. The California(...)

French regulators have taken textured breast implants made by Irish drug giant Allergan off the market. Photograph: Thomas White / Reuters

(...) cancer are being taken off the market in Europe. The implants, which have a textured or slightly(...)

The collaboration between Inflection Biosciences and the University of Texas Cancer Center  aims to explore the effects of the company’s pipeline of potential cancer treatments in head and neck cancer.

University of Texas Cancer Center (MD Anderson). The start-up is working on a new approach to blocking the(...)

  • 1
  • 2
  • 3
  • Next
  • Last »